GUANFACINE Drug Patent Profile
When do Guanfacine patents expire, and what generic alternatives are available?
Guanfacine is a drug marketed by Actavis Elizabeth, Alembic, Apotex, Fosun Wanbang, Impax Labs Inc, Pharmobedient, Rubicon Research, Sandoz, Sun Pharm, Teva Pharms Usa, Twi Pharms, Unichem, Yichang Humanwell, Aiping Pharm Inc, Ajanta Pharma Ltd, Amneal Pharm, Ascent Pharms Inc, Aurobindo Pharma Usa, Epic Pharma Llc, I 3 Pharms, Watson Labs, and Xiromed. and is included in twenty-five NDAs.
The generic ingredient in GUANFACINE is guanfacine hydrochloride. There is one drug master file entry for this compound. Thirty-six suppliers are listed for this compound. Additional details are available on the guanfacine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Guanfacine
A generic version of GUANFACINE was approved as guanfacine hydrochloride by WATSON LABS on October 17th, 1995.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for GUANFACINE?
- What are the global sales for GUANFACINE?
- What is Average Wholesale Price for GUANFACINE?
Summary for GUANFACINE
| US Patents: | 0 |
| Applicants: | 22 |
| NDAs: | 25 |
| Drug Prices: | Drug price information for GUANFACINE |
| Drug Sales Revenues: | Drug sales revenues for GUANFACINE |
| DailyMed Link: | GUANFACINE at DailyMed |
US Patents and Regulatory Information for GUANFACINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Watson Labs | GUANFACINE HYDROCHLORIDE | guanfacine hydrochloride | TABLET;ORAL | 074762-001 | Jun 25, 1997 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Twi Pharms | GUANFACINE HYDROCHLORIDE | guanfacine hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 201408-001 | Jun 2, 2015 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Sandoz | GUANFACINE HYDROCHLORIDE | guanfacine hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 202568-004 | Jun 3, 2015 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Yichang Humanwell | GUANFACINE HYDROCHLORIDE | guanfacine hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 213428-001 | Nov 25, 2020 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Ascent Pharms Inc | GUANFACINE HYDROCHLORIDE | guanfacine hydrochloride | TABLET;ORAL | 220675-002 | Mar 24, 2026 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Unichem | GUANFACINE HYDROCHLORIDE | guanfacine hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 219033-001 | Nov 19, 2024 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
